Bio-Rad Laboratories | BIO - Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
Abbott USD 52.13B 1.3B 2025-12
Agilent USD 6.91B 167M 2025-12
Becton, Dickinson and Co. USD 25.28B 108M 2025-12
Bio Techne USD 2.01B 45.18M 2025-12
Bio-Rad Laboratories USD 7.45B 716.8M 2025-12
Bruker USD 2.49B 625.6M 2025-09
Charles River Laboratories USD 3.16B 240.82M 2025-12
Danaher USD 52.53B 1.46B 2025-12
Exact Sciences USD 2.4B 100.37M 2025-12
General Electric Aerospace USD 18.9B 86M 2025-12
Hologic USD 5.25B 197.2M 2025-12
Illumina USD 2.72B 342M 2025-12
IQVIA Holdings USD 6.5B 343M 2025-12
Laboratory Of America USD 8.62B 93.2M 2025-12
Merck USD 51.85B 2.79B 2025-09
Mettler Toledo International USD -23.64M 225.56M 2025-12
Myriad Genetics USD 368M 4.8M 2025-12
OraSure Technologies USD 340.83M 21.15M 2025-12
Pacific Biosciences Of California USD 5.35M 30.74M 2025-12
Quest Diagnostics USD 7.17B 88M 2025-12
Repligen USD 2.11B 1.66B 2025-12
Revvity USD 7.38B 180.27M 2025-09
Roche Holding CHF 33.8B 758M 2025-12
Siemens EUR 65.48B 3.24B 2025-12
Standard Biotools USD 424.29M 24.63M 2025-12
Thermo Fisher Scientific USD 53.54B 2.38B 2025-12
Tosoh JPY 803.3B 7.06B 2025-12
Waters USD 2.56B 230.55M 2025-12